The results demonstrated that high PAQR3 expression was significantly associated with improved overall survival (HR = 0.32; 95% CI = 0.19–0.56) and disease-free survival (HR = 0.35; 95% CI = 0.20–0.61) in pan-cancer patients. This evidence concerns the gene PAQR3 and cancer.